Clincosm LogoSign in Get a demo

peritoneal cancer

Showing 51 - 75 of 116
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer Trial in Albuquerque (Ketorolac, Placebo)

Active, not recruiting
  • Ovarian Cancer
  • +2 more
  • Albuquerque, New Mexico
    Universtiy of New Mexico Comprehensive Cancer Center
May 18, 2021

Metastatic Ovarian Cancer, Metastatic Fallopian Tube Cancer, Peritoneal Cancer Trial in Herlev (Ipilimumab, Cyclophosphamid,

Recruiting
  • Metastatic Ovarian Cancer
  • +2 more
  • Herlev, Denmark
    National Center for Cancer Immune Therapy (CCIT-DK)
May 7, 2021

Endometrial Cancer, Ovarian Cancer, Cervical Cancer Trial in Boston (temsirolimus, cediranib)

Completed
  • Endometrial Cancer
  • +4 more
  • Boston, Massachusetts
  • +2 more
Apr 20, 2021

Epithelial Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer Trial (Gimatecan)

Not yet recruiting
  • Epithelial Ovarian Cancer
  • +2 more
  • (no location specified)
Apr 15, 2021

Real-life Use of Niraparib in a Patient Access Program in Norway

Completed
  • Ovarian Cancer
  • Peritoneal Cancer
  • Oslo, Norway
    Oslo University Hospital (OUH)
Mar 2, 2021

Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer Trial in United States (Gemcitabine, pazopanib)

Completed
Has Results
  • Ovarian Cancer
  • +2 more
  • Scarborough, Maine
  • +7 more
Feb 8, 2021

Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer Trial in Worldwide (Rucaparib)

Completed
Has Results
  • Ovarian Cancer
  • +3 more
  • San Francisco, California
  • +15 more
Jan 19, 2021

Epithelial Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer Trial in United States (MEK162, MEK inhibitor; oral,

Completed
  • Epithelial Ovarian Cancer
  • +2 more
  • MEK162, MEK inhibitor; oral
  • Paclitaxel, mitotic inhibitor; intravenous
  • Scottsdale, Arizona
  • +3 more
Sep 9, 2020

Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer Trial in Boston (Tumor collection)

Completed
  • Ovarian Cancer
  • +2 more
  • Tumor collection
  • Boston, Massachusetts
  • +3 more
Sep 9, 2020

Minimally Invasive Robotic Surgery, Role in Optimal Debulking

Recruiting
  • Ovarian Cancer
  • +4 more
  • Robotic Interval Debulking Surgery
  • Guildford, Surrey, United Kingdom
    Royal Surrey NHS Foundation Trust
Aug 31, 2020

Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer Trial in United States (Paclitaxel, Carboplatin, Avastin)

Active, not recruiting
  • Ovarian Cancer
  • +2 more
  • Baltimore, Maryland
  • +4 more
Aug 17, 2020

Ovarian Cancer, Endometrial Cancer, Fallopian Cancer Trial in Annandale (E39 peptide (100mcg)/GM-CSF vaccine plus E39 booster,

Completed
  • Ovarian Cancer
  • +3 more
  • E39 peptide (100mcg)/GM-CSF vaccine plus E39 booster
  • +6 more
  • Annandale, Virginia
    Mid-Atlantic Gynecologic Oncology & Pelvic Surgery Associates
Apr 28, 2020

Pelvic Floor Disorders in Survivors of Gynecologic Malignancies

Completed
  • Uterine Cancer
  • +5 more
  • Survey
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Apr 28, 2020

Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer Trial in Pittsburgh (intravenous docetaxel with intraperitoneal

Completed
  • Ovarian Cancer
  • +2 more
  • intravenous docetaxel with intraperitoneal oxaliplatin
  • intravenous oxaliplatin with intraperitoneal docetaxel
  • Pittsburgh, Pennsylvania
    Magee-Womens Hospital of UPMC
Mar 10, 2020

Epithelial Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer Trial in Linz (HIPEC, Carboplatin)

Withdrawn
  • Epithelial Ovarian Cancer
  • +2 more
  • Linz, Austria
    Department of gynaecology, Ordensklinikum Linz Ges.m.b.H, Barmhe
Mar 2, 2020

Spirituality in Coping and Surviving With Ovarian Cancer,

Unknown status
  • Ovarian Cancer
  • +2 more
  • Questionnaire
  • Houston, Texas
  • +3 more
Jan 8, 2020

Ovarian Cancer Stage IIIC, Ovarian Cancer Stage IV, Fallopian Tube Cancer Trial in Seoul (Two cycles of neoadjuvant chemo)

Recruiting
  • Ovarian Cancer Stage IIIC
  • +3 more
  • Two cycles of neoadjuvant chemotherapy
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Dec 7, 2019

Plasma Tumor-promoting Factors and Immune Function After

Recruiting
  • Peritoneal Cancer
  • Chemotherapy-Induced Change
  • PIPAC with oxaliplatin
  • Cytoreductive surgery and Hyperthermic IntraPeritoneal Chemotherapy
  • Tübingen, Germany
    University Hospital Tübingen
Oct 9, 2019

Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer Trial in New York (carboplatin)

Completed
Has Results
  • Ovarian Cancer
  • +2 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Oct 1, 2019

Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer Trial in United Kingdom (TroVax®, Placebo)

Completed
  • Ovarian Cancer
  • +2 more
  • TroVax®
  • Placebo
  • Leeds, West Yorkshire, United Kingdom
  • +11 more
May 8, 2019

Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer Trial in Los Gatos (HIPEC: MMC 30mg @ T0, 10mg @ T45min, HIPEC: MMC +

Unknown status
  • Ovarian Cancer
  • +6 more
  • HIPEC: MMC 30mg @ T0, 10mg @ T45min
  • +3 more
  • Los Gatos, California
    James Lilja
Apr 15, 2019

Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer Trial in Toronto (Cisplatin, Paclitaxel)

Terminated
  • Ovarian Cancer
  • +3 more
  • Toronto, Ontario, Canada
    Princess Margaret Hospital
Feb 13, 2019

Ovarian Cancer, Fallopian Tube Cancer, Endometrial Cancer Trial in Houston (COTI2, Cisplatin)

Unknown status
  • Ovarian Cancer
  • +9 more
  • Houston, Texas
    MD Anderson Cancer Center
Jan 30, 2019

Endometrial Cancer, Fallopian Tube Cancer, Ovarian Cancer Trial in New York (Narrow Band Imaging (NBI))

Completed
  • Endometrial Cancer
  • +7 more
  • Narrow Band Imaging (NBI)
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Nov 6, 2018

Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer Trial in Durham, Charlottesville, Norfolk (BIBF 1120)

Completed
Has Results
  • Ovarian Cancer
  • +2 more
  • BIBF 1120
  • Durham, North Carolina
  • +2 more
Oct 13, 2018